We are pleased to announce the International Live Conference on Drug Discovery, scheduled to be held on March 16, 2024, at 08:00 PM Indian Standard Time, in an online format. The conference will be focused on the theme, "Innovating the Future of Drug Discovery: Emerging Technologies and Novel Approaches," which aims to highlight the latest advancements in the field of drug discovery, with special emphasis on cutting-edge technologies and innovative approaches.
 

In addition to the main theme, the conference will also have a special track dedicated to brain and mental disorders. This track will provide a unique platform for researchers and experts to present and discuss their latest findings in the field of neuroscience, including new drug discoveries, emerging therapies, and their potential applications in the treatment of mental health disorders. The special track aims to explore the challenges and opportunities in drug discovery for brain and mental disorders, and to foster collaboration between researchers and industry professionals working in this important area. We look forward to an engaging and informative conference that will have a positive impact on drug discovery research globally.

Sessions:

• Emerging Technologies in Drug Discovery: AI and Machine Learning

• Novel Approaches in Drug Design and Discovery

• Therapeutic Strategies for Brain and Mental Disorders: New Discoveries and Current Challenges

• Preclinical Development and Clinical Trials: Lessons Learned and Best Practices

• Drug Delivery and Formulation: Novel Approaches to Enhance Efficacy and Safety

• Innovations in Precision Medicine: Opportunities and Challenges in Personalized Drug Discovery

• Regulatory and Ethical Considerations in Drug Discovery and Development

• Investor and Industry Perspectives on Drug Discovery: Opportunities and Challenges

• The Future of Drug Discovery: Perspectives and Prospects
   

Our conference will feature a range of sessions, including presentations, posters, and interactive discussions, that will provide attendees with opportunities to engage with the latest research and advances in drug discovery. By participating in this conference, we hope to facilitate collaborations and inspire new ideas that will lead to better diagnosis, treatment, and care for individuals with brain and mental problems.

Thank you for your interest in this conference, and we look forward to your participation in this exciting event.

Publicly Available Financial Data on Drug Discovery and Development for Brain and Mental Disorders

1. The National Institute of Mental Health (NIMH) spent approximately $1.9 billion on research related to mental health in 2020, which includes funding for drug discovery and development. You can find more information on NIMH funding at: https://report.nih.gov/categorical_spending.aspx

2. According to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA), member companies spent $83 billion on research and development in 2019, including investments in treatments for neurological and psychiatric disorders. You can find more information on PhRMA's annual report at: https://www.phrma.org/annual-report

3. The World Health Organization (WHO) estimates that the global economic burden of mental illness is $2.5 trillion per year, which includes the costs of healthcare, lost productivity, and other indirect costs. You can find more information on WHO's data on global health expenditures at: https://www.who.int/data/gho/data/themes/health-expenditure.

4. The National Institutes of Health (NIH) provides data on the funding for research related to neurological and psychiatric disorders, including drug discovery and development. In 2020, the NIH spent approximately $1.8 billion on research related to neuroscience and behavior. You can find more information on NIH funding at: https://report.nih.gov/categorical_spending.aspx.

5. The National Alliance on Mental Illness (NAMI) estimates that the total economic cost of untreated mental illness in the United States is over $300 billion per year, which includes healthcare costs, lost productivity, and other indirect costs. You can find more information on NAMI's data on mental health spending at: https://www.nami.org/About-NAMI/Publications-Reports/Public-Policy-Reports/The-Economic-Burdens-of-Excessively-Low-Wages-for-Direct-Support-Professionals.